Screener
Haemonetics HAE Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 |
|---|---|---|
| Research and development | 16,200 | 16,261 |
| Selling, general and administrative | 118,941 | 110,719 |
| Amortization of acquired intangible assets | 10,204 | 11,392 |
| Total operating expenses | 145,345 | 138,372 |
| Operating income | 57,458 | 53,872 |
| Interest and other expense, net | (9,884) | (8,703) |
| Income before provision for income taxes | 47,574 | 45,169 |
| Provision for income taxes | 14,564 | 11,138 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's total operating expenses?
- Haemonetics (HAE) reported total operating expenses of $145.35M in Q2 2026.
- How has Haemonetics's total operating expenses changed year-over-year?
- Haemonetics's total operating expenses increased by 5.0% year-over-year, from $138.37M to $145.35M.
- What is the long-term trend for Haemonetics's total operating expenses?
- Over 4 years (2022 to 2026), Haemonetics's total operating expenses has grown at a 10.4% compound annual growth rate (CAGR), from $424.75M to $630.85M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about Haemonetics's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude